• Images
  • Videos
  • Vectors
  • Low Budget
  • Press

Stock Photo - 20 November 2023, NoW, Cologne: A ship sails past the Bayer Group plant in the Chempark in the evening. Bayer has discontinued a study with an important drug hopeful due to lack of efficacy. A Phase III study investigating the drug asundexiane in patients with atrial fibrillation and stroke risk was terminated prematurely, the company announced late on Sunday evening. Photo: Thomas Banneyer/dpa. - Cologne/NoW/Germany

Stock Photo: 20 November 2023, NoW, Cologne: A ship sails past the Bayer Group plant in the Chempark in the evening. Bayer has discontinued a study with an important drug.

Royalty Free License

Choose the resolution that best suits your needs

Size pxcm ppi Price
XS 500 KB A10+ 512 x 341 px 72
S 2 MB A8+ 1025 x 682 px 300
M 10 MB A5 2291 x 1525 px 300
L 26 MB A4 3694 x 2459 px 300
Available only for EDITORIAL USE
This image is not included in the easySUBSCRIPTIONS PLANS
Buy now
Add to cart
DELIVERY: Image compressed as JPG

Details

Image Code: PAH-231120-99-18465-dpai User license: Rights Managed Shooting date: 11/20/2023 HI-RES availability: Up to L 26 MB A4 (3694 x 2459 px - 12.3" x 8.2" - 300 ppi)

Important Information

Releases: No signed releases for this image.

Availability: Image availability cannot be guaranteed until time of purchase.

Searchable keywords

Choose multiple keywords